Eikon Therapeutics, Inc. (EIKN)

9.21 -1.52 (-14.17%) USD  |  NASDAQ  |  Sep 10, 16:00
9.12 -0.09 (-0.98%) After-Hours: 05:36
More

Eikon Therapeutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for EIKN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Assets (Quarterly) Chart
Start Trial

Historical EV to Assets (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --
Date Value
March 31, 2026 --

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

View EV to Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

View EV to Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade
Vericel Corp. Upgrade

EV to Assets (Quarterly) Related Metrics

EV to Earnings Upgrade